You searched for "Genetic"
Tinnitus in patients on therapy with PPI and in PPI non–users
Tinnitus is a chronic and debilitating condition and approximately 10% of the population is afflicted. A myriad of pharmacological treatments for tinnitus are available but only a few controlled studies have shown positive results. The relationship between proton pump inhibitors...
Demonstrating unobservable effects of therapy through PROMS: a review
Ultimately, healthcare should meet the needs of the people it is designed for. One way of measuring this is using patient-reported outcome measures (PROMS). These tools capture the patient’s perspective and have been described as demonstrating the unobservable effects of...The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies
Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...The European School of Interdisciplinary Tinnitus
Scientific careers in tinnitus are expanding beyond any single discipline to embrace interdisciplinary collaboration and knowledge exchange. Natalia Trpchevska and Christopher R Cederroth present an overview of an innovative EU-funded training programme called the ‘European School of Interdisciplinary Tinnitus’, and...The European TINNET COST Action BM1306
Winfried Schlee describes how a major European funding award is bringing together experts who are committed to collectively developing a better understanding of tinnitus. This work is vital if we are to pioneer effective treatments for the condition in its...4th Annual Inner Ear Disorders Therapeutics Summit
Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...Kallmann’s Syndrome
‘A rose by any other name would smell as sweet.’ (Shakespeare) Kallmann’s Syndrome (KS), or hereditary hypogonadal anosmia, is a rare genetic disorder characterised by delayed or absent puberty and anosmia. It is named after Franz Kallmann, but he was...
Impact of delaying otologic surgery
In this Belgian study, the authors looked at the impact of delaying otologic surgery by sending an online survey to 44 adult patients diagnosed with benign ear pathology whose surgery was postponed due to the COVID-19 pandemic. The questionnaire was...
